Rhythm Pharmaceuticals Inc. Email Format

Biotechnology ResearchMassachusetts, United States201-500 Employees

Rhythm Pharmaceuticals is a Boston-based, global biotechnology company focused on rare neuroendocrine diseases, developing medicines intended to address the underlying biology of these conditions. It aims to serve patients whose diseases have been untreatable or undertreated, while providing support to healthcare providers, patients, and families. The company is advancing a broad clinical program centered on MC4R pathway diseases, including investigational MC4R agonists, and maintains a preclinical portfolio for congenital hyperinsulinism.

Its lead asset is being commercialized in North America, Europe, and other regions, reflecting its current market focus. In 2026, Rhythm participated in the Endocrine Society's annual meeting in Chicago, presenting clinical data from its MC4R-related programs, signaling ongoing clinical activity. The firm is described as a mid-sized organization with a global footprint within the biotechnology sector, oriented toward translating rare-disease biology into therapies.

Sign up for free to view info

Company overview Employee directory